{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:40:14Z","timestamp":1777596014546,"version":"3.51.4"},"reference-count":143,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Helsinki University","award":["212\/51\/2011"],"award-info":[{"award-number":["212\/51\/2011"]}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["#267761"],"award-info":[{"award-number":["#267761"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.bcp.2015.07.031","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T21:59:32Z","timestamp":1438207172000},"page":"542-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Methadone\u2019s effect on nAChRs\u2014a link between methadone use and smoking?"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2409-3785","authenticated-orcid":false,"given":"Reeta","family":"Talka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimo K.","family":"Tuominen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Outi","family":"Salminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2015.07.031_bib0005","first-page":"615","article-title":"Methadone","volume":"109","author":"Sim","year":"1973","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.bcp.2015.07.031_bib0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone-metabolism, pharmacokinetics and interactions","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2015.07.031_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003409.pub4","article-title":"Methadone at tapered doses for the management of opioid withdrawal","volume":"2","author":"Amato","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bcp.2015.07.031_bib0020","doi-asserted-by":"crossref","first-page":"PL45","DOI":"10.1016\/0024-3205(94)00937-6","article-title":"The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine","volume":"56","author":"Kristensen","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2015.07.031_bib0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0304-3940(95)11364-3","article-title":"Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord","volume":"187","author":"Ebert","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2015.07.031_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1056-8719(00)00043-5","article-title":"Methadone: a review of its pharmacokinetic\/pharmacodynamic properties","volume":"42","author":"Garrido","year":"1999","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bcp.2015.07.031_bib0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ntr\/ntr048","article-title":"Smoking prevalence in addiction treatment: a review","volume":"13","author":"Guydish","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.bcp.2015.07.031_bib0040","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1037\/1064-1297.15.2.144","article-title":"Patterns of smoking and methadone dose in drug treatment patients","volume":"15","author":"Richter","year":"2007","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0045","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.addbeh.2006.01.006","article-title":"Cigarette smoking and interest in quitting in methadone maintenance patients","volume":"31","author":"Nahvi","year":"2006","journal-title":"Addict. Behav."},{"key":"10.1016\/j.bcp.2015.07.031_bib0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/JCP.0b013e3181a39113","article-title":"Methadone-nicotine interactions in methadone maintenance treatment patients","volume":"29","author":"Elkader","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0055","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/ntr\/nts274","article-title":"A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine","volume":"15","author":"Chisolm","year":"2013","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.bcp.2015.07.031_bib0060","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0022-3565(25)21845-6","article-title":"Effects of methadone on human cigarette smoking and subjective ratings","volume":"229","author":"Chait","year":"1984","journal-title":"J. Pharmacol. Exp.Ther."},{"key":"10.1016\/j.bcp.2015.07.031_bib0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1037\/1064-1297.8.1.97","article-title":"Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals","volume":"8","author":"Frosch","year":"2000","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0376-8716(98)00020-9","article-title":"Effects of nicotine on methadone self-administration in humans","volume":"50","author":"Spiga","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bcp.2015.07.031_bib0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/105504901750227804","article-title":"Interest in smoking cessation among injection drug users","volume":"10","author":"Clarke","year":"2001","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.bcp.2015.07.031_bib0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/02791072.1991.10472237","article-title":"Treating cigarette smoking in methadone maintenance clients","volume":"23","author":"Story","year":"1991","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.bcp.2015.07.031_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00427594","article-title":"Effects of heroin self-administration on cigarette smoking","volume":"67","author":"Mello","year":"1980","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bcp.2015.07.031_bib0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.addbeh.2010.05.003","article-title":"Temporal changes of smoking status and motivation among Chinese heroin-dependent, methadone-maintained smokers","volume":"35","author":"Li","year":"2010","journal-title":"Addict. Behav."},{"key":"10.1016\/j.bcp.2015.07.031_bib0095","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1081\/JA-200042162","article-title":"Self-reported effects of methadone on cigarette smoking in methadone-maintained subjects","volume":"40","author":"Baran-Furga","year":"2005","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.bcp.2015.07.031_bib0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2004.09.006","article-title":"Deaths of clients in methadone treatment in Texas: 1994\u20132002","volume":"78","author":"Maxwell","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bcp.2015.07.031_bib0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.pra.0000351884.83377.e2","article-title":"Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts","volume":"15","author":"Fareed","year":"2009","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.bcp.2015.07.031_bib0110","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/JGP.0b013e31816ff35a","article-title":"The prevalence of mental and physical health disorders among older methadone patients","volume":"16","author":"Rosen","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.bcp.2015.07.031_bib0115","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.1996.03530380039029","article-title":"Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort","volume":"275","author":"Hurt","year":"1996","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bcp.2015.07.031_bib0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2105\/AJPH.91.2.296","article-title":"Tobacco use and quit attempts among methadone maintenance clients","volume":"91","author":"Richter","year":"2001","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.bcp.2015.07.031_bib0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jsat.2009.10.001","article-title":"Smoking cessation interventions among individuals in methadone maintenance: a brief review","volume":"38","author":"Okoli","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.bcp.2015.07.031_bib0130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1360-0443.2006.01406.x","article-title":"A smoking cessation intervention for the methadone-maintained","volume":"101","author":"Stein","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.bcp.2015.07.031_bib0135","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1046\/j.1360-0443.2002.00221.x","article-title":"Smoking cessation in methadone maintenance","volume":"97","author":"Shoptaw","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.bcp.2015.07.031_bib0140","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0306-4603(02)00259-9","article-title":"The impact of smoking cessation on drug abuse treatment outcome","volume":"28","author":"Lemon","year":"2003","journal-title":"Addict. Behav."},{"key":"10.1016\/j.bcp.2015.07.031_bib0145","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009329.pub2","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"5","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bcp.2015.07.031_bib0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1874473711306010009","article-title":"Cigarette smoking in methadone maintained patients: an up-to-date review","volume":"6","author":"Zirakzadeh","year":"2013","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.bcp.2015.07.031_bib0155","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1085\/jgp.105.6.701","article-title":"Monovalent and divalent cation permeability and block of neuronal nicotinic receptor channels in rat parasympathetic ganglia","volume":"105","author":"Nutter","year":"1995","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0165","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","article-title":"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system","volume":"47","author":"Dani","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2015.07.031_bib0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","article-title":"Diversity of vertebrate nicotinic acetylcholine receptors","volume":"56","author":"Millar","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2015.07.031_bib0180","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1099420","article-title":"Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization","volume":"306","author":"Tapper","year":"2004","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2015.07.031_bib0185","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1038\/sj.bjp.0707510","article-title":"Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission","volume":"153","author":"Exley","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-011-2422-1","article-title":"Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice","volume":"220","author":"Besson","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bcp.2015.07.031_bib0195","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/npp.2011.299","article-title":"Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia","volume":"37","author":"Brunzell","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2015.07.031_bib0200","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0166-2236(99)01471-X","article-title":"Nicotinic receptors in the brain: correlating physiology with function","volume":"22","author":"Jones","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bcp.2015.07.031_bib0205","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/add.12899","article-title":"Global statistics on addictive behaviours: 2014 status report","volume":"110","author":"Gowing","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.bcp.2015.07.031_bib0210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neubiorev.2006.09.008","article-title":"Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development","volume":"31","author":"Janhunen","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bcp.2015.07.031_bib0215","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuropharm.2013.04.028","article-title":"Molecules and circuits involved in nicotine addiction: The many faces of smoking","volume":"76","author":"Picciotto","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2015.07.031_bib0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neubiorev.2005.04.016","article-title":"The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse","volume":"30","author":"Pierce","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bcp.2015.07.031_bib0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/syn.890160105","article-title":"Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area","volume":"16","author":"Nisell","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.bcp.2015.07.031_bib0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/382255a0","article-title":"Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs","volume":"382","author":"Pontieri","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.07.031_bib0235","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1046\/j.1460-9568.2001.02009.x","article-title":"Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections","volume":"15","author":"Ferrari","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2015.07.031_bib0240","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1476-5381.1992.tb09067.x","article-title":"The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity","volume":"105","author":"Benwell","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0245","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0896-6273(00)00042-8","article-title":"Long-term potentiation of excitatory inputs to brain reward areas by nicotine","volume":"27","author":"Mansvelder","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2015.07.031_bib0250","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"rugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.07.031_bib0255","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2004.05.015","article-title":"Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine","volume":"494","author":"Janhunen","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0260","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1523\/JNEUROSCI.21-05-01452.2001","article-title":"Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei","volume":"21","author":"Klink","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2015.07.031_bib0265","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1523\/JNEUROSCI.23-21-07820.2003","article-title":"Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice","volume":"23","author":"Champtiaux","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2015.07.031_bib0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(00)00005-4","article-title":"Presynaptic nicotinic receptors modulating dopamine release in the rat striatum","volume":"393","author":"Wonnacott","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0275","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.22-20-08785.2002","article-title":"Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum","volume":"22","author":"Zoli","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2015.07.031_bib0280","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1124\/mol.65.6.1526","article-title":"Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice","volume":"65","author":"Salminen","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/34413","article-title":"Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine","volume":"391","author":"Picciotto","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.07.031_bib0290","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jcpt.12171","article-title":"Involvement of neuronal beta2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies","volume":"39","author":"Simmons","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bcp.2015.07.031_bib0295","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/mol.112.083659","article-title":"Nicotinic receptors in addiction pathways","volume":"83","author":"Leslie","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0300","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.neuropharm.2012.04.015","article-title":"Alpha3beta4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo","volume":"63","author":"McCallum","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2015.07.031_bib0305","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1471-4159.2005.03279.x","article-title":"Methadone increases intracellular calcium in SH-SY5Y and SH-EP1-halpha7 cells by activating neuronal nicotinic acetylcholine receptors","volume":"94","author":"Pakkanen","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2015.07.031_bib0310","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/bcpt.12317","article-title":"Methadone is a non-competitive antagonist at the alpha4beta2 and alpha3* nicotinic acetylcholine receptors and an agonist at the alpha7 nicotinic acetylcholine receptor","volume":"116","author":"Talka","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0315","article-title":"Diversity of native nicotinic receptor subtypes in mammalian brain","author":"Zoli","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2015.07.031_bib0320","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1124\/mol.51.5.776","article-title":"Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y","volume":"51","author":"Peng","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0325","series-title":"Nicotinic Receptors and the Nervous Syste","first-page":"3","article-title":"Some methods for studies of nicotinic acetylcholine receptor pharmacology","author":"Lukas","year":"2002"},{"key":"10.1016\/j.bcp.2015.07.031_bib0330","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1476-5381.1996.tb15195.x","article-title":"delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells","volume":"117","author":"Connor","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0335","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1471-4159.2002.00951.x","article-title":"Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography","volume":"82","author":"Perry","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2015.07.031_bib0340","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.mp.4002154","article-title":"Alpha-5\/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking","volume":"13","author":"Berrettini","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bcp.2015.07.031_bib0345","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ntr\/ntr118","article-title":"Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis","volume":"13","author":"Ware","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.bcp.2015.07.031_bib0350","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0022-3565(24)29338-1","article-title":"Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs","volume":"299","author":"Xiao","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.07.031_bib0355","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/cne.902840212","article-title":"Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat","volume":"284","author":"Wada","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0360","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/mol.54.6.1124","article-title":"Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes","volume":"54","author":"Zwart","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0365","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.pnpbp.2007.12.012","article-title":"Tobacco\/nicotine and endogenous brain opioids","volume":"32","author":"Xue","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2015.07.031_bib0370","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bcp.2015.07.031_bib0375","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/138945007779315605","article-title":"Nociceptin\/orphanin FQ peptide receptors: pharmacology and clinical implications","volume":"8","author":"Chiou","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bcp.2015.07.031_bib0380","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0304-3940(90)90491-Q","article-title":"Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain","volume":"113","author":"Davenport","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2015.07.031_bib0385","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1074\/mcp.M112.024828","article-title":"Chronic nicotine treatment impacts the regulation of opioid and non-opioid peptides in the rat dorsal striatum","volume":"12","author":"Petruzziello","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bcp.2015.07.031_bib0390","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1046\/j.1471-4159.1995.64041878.x","article-title":"Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine","volume":"64","author":"Dhatt","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2015.07.031_bib0395","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0196-9781(91)90183-P","article-title":"Nicotine-induced alteration in Tyr-Gly\u2013Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity","volume":"12","author":"Houdi","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.bcp.2015.07.031_bib0400","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(98)00454-5","article-title":"Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA","volume":"799","author":"Houdi","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2015.07.031_bib0405","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(02)00240-9","article-title":"Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse","volume":"325","author":"Isola","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2015.07.031_bib0410","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(99)01095-1","article-title":"The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats","volume":"822","author":"Wewers","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2015.07.031_bib0415","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.neuron.2005.05.005","article-title":"Mu-opioid receptor and CREB activation are required for nicotine reward","volume":"46","author":"Walters","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2015.07.031_bib0420","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0091-3057(02)01002-X","article-title":"Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice","volume":"74","author":"Zarrindast","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bcp.2015.07.031_bib0425","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02244930","article-title":"Naloxone precipitates nicotine abstinence syndrome in the rat","volume":"112","author":"Malin","year":"1993","journal-title":"Psychopharmacology Berl.)"},{"key":"10.1016\/j.bcp.2015.07.031_bib0430","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archpsyc.56.7.663","article-title":"Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence","volume":"56","author":"Krishnan-Sarin","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bcp.2015.07.031_bib0435","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1523\/JNEUROSCI.22-24-10935.2002","article-title":"Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice","volume":"22","author":"Berrendero","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2015.07.031_bib0440","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2009.03.013","article-title":"Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin","volume":"56","author":"Trigo","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2015.07.031_bib0445","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1523\/JNEUROSCI.3008-04.2005","article-title":"Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene","volume":"25","author":"Berrendero","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2015.07.031_bib0450","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0740-5472(03)00065-5","article-title":"Why do so many drug users smoke","volume":"25","author":"McCool","year":"2003","journal-title":"J. Subst. Abuse Treat."},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2015.07.031_bib0455","first-page":"S135","article-title":"Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration","volume":"117","author":"Galea","year":"2002","journal-title":"Public Health Rep"},{"key":"10.1016\/j.bcp.2015.07.031_bib0460","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3109\/10826089509055846","article-title":"Smoking cessation leads to reduced stress, but why","volume":"30","author":"Parrott","year":"1995","journal-title":"Int. J. Addict."},{"key":"10.1016\/j.bcp.2015.07.031_bib0465","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1360-0443.1995.tb01041.x","article-title":"Stress modulation over the day in cigarette smokers","volume":"90","author":"Parrott","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.bcp.2015.07.031_bib0470","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0140-6736(00)03409-7","article-title":"Methadone, ciprofloxacin, and adverse drug reactions","volume":"356","author":"Herrlin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2015.07.031_bib0475","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00004714-199704000-00010","article-title":"Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone","volume":"17","author":"Eap","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0480","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2125.2009.03568.x","article-title":"Effects of nicotine on cytochrome P450 2A6 and 2E1 activities","volume":"69","author":"Hukkanen","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0485","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2125.2008.03312.x","article-title":"Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment","volume":"67","author":"Shiran","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0490","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1124\/dmd.110.032474","article-title":"a substrate and mechanism-based inhibitor of CYP19 (aromatase)","volume":"38","author":"Lu","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2015.07.031_bib0495","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF00542117","article-title":"Pharmacokinetics of methadone in methadone maintenance treatment: characterization of therapeutic failures","volume":"25","author":"Nilsson","year":"1983","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0500","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0009-9236(99)90090-5","article-title":"Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships","volume":"65","author":"Dyer","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2015.07.031_bib0505","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bcp.2015.07.031_bib0510","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clpt.2005.08.011","article-title":"Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment","volume":"78","author":"Crettol","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2015.07.031_bib0515","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1369-1600.2011.00349.x","article-title":"CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction","volume":"18","author":"Levran","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0520","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/dmd.115.064352","article-title":"Differences in methadone metabolism by CYP2B6 variants","volume":"43","author":"Gadel","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2015.07.031_bib0525","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00194951","article-title":"Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts","volume":"48","author":"de","year":"1995","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0530","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jat\/20.6.362","article-title":"Determination of methadone and its N-demethylation metabolites in biological specimens by GC\u2013PICI-\u2013MS","volume":"20","author":"Alburges","year":"1996","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0535","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-3565(25)05269-3","article-title":"The metabolic fate of the optical isomers of methadone","volume":"109","author":"Sung","year":"1953","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.07.031_bib0540","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/bcp.12051","article-title":"Pharmacological maintenance treatments of opiate addiction","volume":"77","author":"Bell","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0545","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/jhg.2012.139","article-title":"OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study","volume":"58","author":"Chen","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bcp.2015.07.031_bib0550","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pbb.2013.10.018","article-title":"Pharmacogenetics of OPRM1","volume":"123","author":"Crist","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bcp.2015.07.031_bib0555","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1744-9081-2-28","article-title":"The mu-opioid receptor gene and smoking initiation and nicotine dependence","volume":"2","author":"Zhang","year":"2006","journal-title":"Behav.Brain Funct."},{"key":"10.1016\/j.bcp.2015.07.031_bib0560","doi-asserted-by":"crossref","first-page":"9268","DOI":"10.1073\/pnas.1018699108","article-title":"Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers","volume":"108","author":"Ray","year":"2011","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.07.031_bib0565","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2013.01.005","article-title":"Nicotine-morphine interactions at alpha4beta2, alpha7 and alpha3(*) nicotinic acetylcholine receptors","volume":"701","author":"Talka","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0570","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2011.01.040","article-title":"Blocking alpha4beta2 and alpha7 nicotinic acetylcholine receptors inhibits the reinstatement of morphine-induced CPP by drug priming in mice","volume":"220","author":"Feng","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.bcp.2015.07.031_bib0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(95)00761-X","article-title":"Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice","volume":"298","author":"Zarrindast","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0580","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejphar.2008.03.028","article-title":"Morphine-nicotine interaction in conditioned place preference in mice after chronic nicotine exposure","volume":"587","author":"Vihavainen","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0585","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1111\/bph.12741","article-title":"The alpha3beta4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies","volume":"171","author":"Muldoon","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0590","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s11095-006-9088-0","article-title":"Non-competitive inhibitory activities of morphinan and morphine derivatives at the alpha 3 beta 4 neuronal nicotinic acetylcholine receptor determined using nonlinear chromatography and chemometric techniques","volume":"23","author":"Jozwiak","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bcp.2015.07.031_bib0595","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00427902","article-title":"Buprenorphine effects on cigarette smoking","volume":"86","author":"Mello","year":"1985","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bcp.2015.07.031_bib0600","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/14622200210124012","article-title":"An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependent on cocaine and opioids","volume":"4","author":"Mutschler","year":"2002","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.bcp.2015.07.031_bib0605","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3390\/ijerph9030932","article-title":"Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy","volume":"9","author":"Pajusco","year":"2012","journal-title":"Int. J. Public. Health Environ. Res."},{"key":"10.1016\/j.bcp.2015.07.031_bib0610","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.addbeh.2014.04.023","article-title":"Spontaneous reductions in smoking during double-blind buprenorphine detoxification","volume":"39","author":"Patrick","year":"2014","journal-title":"Addict. Behav."},{"key":"10.1016\/j.bcp.2015.07.031_bib0615","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/S0028-3908(00)00157-X","article-title":"The opioid antagonist naltrexone inhibits activity and alters expression of alpha7 and alpha4beta2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs","volume":"39","author":"Almeida","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2015.07.031_bib0620","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.bmcl.2004.01.004","article-title":"Sensitivity of neuronal nicotinic acetylcholine receptors to the opiate antagonists naltrexone and naloxone: receptor blockade and up-regulation","volume":"14","author":"Almeida","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2015.07.031_bib0625","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0014-5793(85)81145-5","article-title":"The narcotic antagonist naltrexone has a biphasic effect on the nicotinic acetylcholine receptor","volume":"182","author":"Madsen","year":"1985","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2015.07.031_bib0630","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0006-8993(01)02388-5","article-title":"Naloxone inhibits nicotine-induced receptor current and catecholamine secretion in bovine chromaffin cells","volume":"903","author":"Tome","year":"2001","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bcp.2015.07.031_bib0635","article-title":"Detoxification treatments for opiate dependent adolescents","author":"Minozzi","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl 17","key":"10.1016\/j.bcp.2015.07.031_bib0640","doi-asserted-by":"crossref","first-page":"79","DOI":"10.15288\/jsads.2014.s17.79","article-title":"Pharmacotherapy of alcohol use disorders: seventy-five years of progress","volume":"75","author":"Zindel","year":"2014","journal-title":"J. Stud. Alcohol Drugs Suppl."},{"issue":"4","key":"10.1016\/j.bcp.2015.07.031_bib0645","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003086.pub2","article-title":"Opioid antagonists for smoking cessation","author":"David","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bcp.2015.07.031_bib0650","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0022-3565(24)39320-6","article-title":"Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors","volume":"293","author":"Hernandez","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.07.031_bib0655","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1124\/jpet.104.075093","article-title":"Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity","volume":"312","author":"Damaj","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.07.031_bib0660","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0922-4106(95)00080-1","article-title":"Physostigmine, galanthamine and codeine act as \u2018noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells","volume":"290","author":"Storch","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0665","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00894-005-0057-z","article-title":"Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the blind docking approach","volume":"12","author":"Iorga","year":"2006","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.bcp.2015.07.031_bib0670","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bjp.0704703","article-title":"Inhibitory effects of tramadol on nicotinic acetylcholine receptors in adrenal chromaffin cells and in Xenopus oocytes expressing alpha 7 receptors","volume":"136","author":"Shiraishi","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.07.031_bib0675","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006103.pub6","article-title":"Nicotine receptor partial agonists for smoking cessation","author":"Cahill","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bcp.2015.07.031_bib0680","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/add.12631","article-title":"Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial","volume":"109","author":"Nahvi","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.bcp.2015.07.031_bib0685","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.drugalcdep.2013.07.005","article-title":"Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial","volume":"133","author":"Stein","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bcp.2015.07.031_bib0690","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00213-012-2717-x","article-title":"Varenicline decreases alcohol consumption in heavy-drinking smokers","volume":"223","author":"Mitchell","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bcp.2015.07.031_bib0695","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/ADM.0b013e31829623f4","article-title":"A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence","volume":"7","author":"Litten","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.bcp.2015.07.031_bib0700","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1521-0391.2013.12037.x","article-title":"Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction","volume":"22","author":"Nocente","year":"2013","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.bcp.2015.07.031_bib0705","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.addbeh.2014.11.007","article-title":"Varenicline for opioid withdrawal in patients with chronic pain: a randomized, single-blinded, placebo controlled pilot trial","volume":"42","author":"Hooten","year":"2015","journal-title":"Addict. Behav."},{"key":"10.1016\/j.bcp.2015.07.031_bib0710","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation","volume":"48","author":"Coe","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2015.07.031_bib0715","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.tips.2007.05.003","article-title":"Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation","volume":"28","author":"Rollema","year":"2007","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215004207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215004207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T20:14:32Z","timestamp":1748549672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295215004207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":143,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0006295215004207"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2015.07.031","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methadone\u2019s effect on nAChRs\u2014a link between methadone use and smoking?","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2015.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}